Search

Lynsey C. Eiseman

Examiner (ID: 13216)

Most Active Art Unit
3769
Art Unit(s)
3792, 3769, 3796, 3762
Total Applications
758
Issued Applications
333
Pending Applications
92
Abandoned Applications
349

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19091172 [patent_doc_number] => 11952604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-09 [patent_title] => Enzymatic method for preparing Rebaudioside J [patent_app_type] => utility [patent_app_number] => 17/805626 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2177 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17805626 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/805626
Enzymatic method for preparing Rebaudioside J Jun 5, 2022 Issued
Array ( [id] => 17867381 [patent_doc_number] => 20220290117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => ENZYMATIC PRODUCTION OF HEXOSES [patent_app_type] => utility [patent_app_number] => 17/825484 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/825484
Enzymatic production of hexoses May 25, 2022 Issued
Array ( [id] => 18537789 [patent_doc_number] => 20230242889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => RECOMBINASE POLYMERASE AMPLIFICATION [patent_app_type] => utility [patent_app_number] => 17/750758 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17750758 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/750758
Recombinase polymerase amplification May 22, 2022 Issued
Array ( [id] => 18093529 [patent_doc_number] => 20220411870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors [patent_app_type] => utility [patent_app_number] => 17/748110 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 127953 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748110
Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors May 18, 2022 Pending
Array ( [id] => 17871253 [patent_doc_number] => 20220293990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => ELECTRON CARRIER, ELECTRON CARRIER PRODUCTION METHOD, AND ELECTRON TRANSFER METHOD [patent_app_type] => utility [patent_app_number] => 17/748678 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748678 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748678
ELECTRON CARRIER, ELECTRON CARRIER PRODUCTION METHOD, AND ELECTRON TRANSFER METHOD May 18, 2022 Pending
Array ( [id] => 18295918 [patent_doc_number] => 20230105604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => COMPOSITION INCLUDING I2SCN- IONS AND/OR I(SCN)2- IONS [patent_app_type] => utility [patent_app_number] => 17/747572 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/747572
COMPOSITION INCLUDING I2SCN- IONS AND/OR I(SCN)2- IONS May 17, 2022 Abandoned
Array ( [id] => 17837728 [patent_doc_number] => 20220275033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => MODIFIED CYANOBACTERIUM, MODIFIED CYANOBACTERIUM PRODUCTION METHOD, AND PROTEIN PRODUCTION METHOD [patent_app_type] => utility [patent_app_number] => 17/747607 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747607 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/747607
Modified cyanobacterium, modified cyanobacterium production method, and protein production method May 17, 2022 Issued
Array ( [id] => 19862585 [patent_doc_number] => 20250101371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => MICROBIAL STRAIN EXPRESSING AN INVERTASE/SUCROSE HYDROLASE [patent_app_type] => utility [patent_app_number] => 18/561246 [patent_app_country] => US [patent_app_date] => 2022-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561246 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/561246
Microbial strain expressing an invertase/sucrose hydrolase May 16, 2022 Issued
Array ( [id] => 18406119 [patent_doc_number] => 20230167470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => METHOD AND STRAINS FOR REDUCING BYPRODUCT SUCCINIC ACID IN FERMENTATION PROCESS OF L-MALIC ACID AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/744778 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5655 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744778 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744778
Method and strains for reducing byproduct succinic acid in fermentation process of L-malic acid and use thereof May 15, 2022 Issued
Array ( [id] => 17830443 [patent_doc_number] => 20220267747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells [patent_app_type] => utility [patent_app_number] => 17/741326 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/741326
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells May 9, 2022 Abandoned
Array ( [id] => 19521333 [patent_doc_number] => 12123045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-22 [patent_title] => Genetically modified cells that produce C6-C10 fatty acid derivatives [patent_app_type] => utility [patent_app_number] => 17/661613 [patent_app_country] => US [patent_app_date] => 2022-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31522 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17661613 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/661613
Genetically modified cells that produce C6-C10 fatty acid derivatives May 1, 2022 Issued
Array ( [id] => 17807744 [patent_doc_number] => 20220259579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES [patent_app_type] => utility [patent_app_number] => 17/732927 [patent_app_country] => US [patent_app_date] => 2022-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16881 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -138 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732927 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/732927
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES Apr 28, 2022 Abandoned
Array ( [id] => 17946136 [patent_doc_number] => 20220333153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => ULTRASENSITIVE ELECTROCHEMICAL BIOSENSORS [patent_app_type] => utility [patent_app_number] => 17/732296 [patent_app_country] => US [patent_app_date] => 2022-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/732296
ULTRASENSITIVE ELECTROCHEMICAL BIOSENSORS Apr 27, 2022 Abandoned
Array ( [id] => 17792531 [patent_doc_number] => 20220251622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => Method for Producing Protein [patent_app_type] => utility [patent_app_number] => 17/730750 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/730750
Method for producing protein Apr 26, 2022 Issued
Array ( [id] => 18020952 [patent_doc_number] => 20220372451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI [patent_app_type] => utility [patent_app_number] => 17/729120 [patent_app_country] => US [patent_app_date] => 2022-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729120 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/729120
PRODUCTION OF PYRUVATE OR PRODUCTS DERIVED FROM PYRUVATE USING MODIFIED ESCHERICHIA COLI Apr 25, 2022 Abandoned
Array ( [id] => 19650054 [patent_doc_number] => 12171814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same [patent_app_type] => utility [patent_app_number] => 18/287223 [patent_app_country] => US [patent_app_date] => 2022-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 9097 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287223 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287223
Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same Apr 17, 2022 Issued
Array ( [id] => 18620633 [patent_doc_number] => 11753661 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Process for the biological production of methacrylic acid and derivatives thereof [patent_app_type] => utility [patent_app_number] => 17/720739 [patent_app_country] => US [patent_app_date] => 2022-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 29 [patent_no_of_words] => 24807 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720739 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/720739
Process for the biological production of methacrylic acid and derivatives thereof Apr 13, 2022 Issued
Array ( [id] => 17897335 [patent_doc_number] => 20220306997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION [patent_app_type] => utility [patent_app_number] => 17/711270 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711270
GENETIC ENGINEERING OF FUNGI TO MODULATE TRYPTAMINE EXPRESSION Mar 31, 2022 Pending
Array ( [id] => 17720437 [patent_doc_number] => 20220213157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS [patent_app_type] => utility [patent_app_number] => 17/656221 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656221 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/656221
ELECTRICAL CONDUCTORS AND METHODS OF CONDUCTING IONS USING CALSEQUESTRIN PROTEINS Mar 22, 2022 Pending
Array ( [id] => 17852255 [patent_doc_number] => 20220282297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E [patent_app_type] => utility [patent_app_number] => 17/697043 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697043
BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E Mar 16, 2022 Pending
Menu